Wealth Management Associates, Inc. Eli Lilly & CO Transaction History

Wealth Management Associates, Inc.

$233 Billion
Q1 2025

A detailed history of Wealth Management Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealth Management Associates, Inc. holds 3,692 shares of LLY stock, worth $2.72 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

3,692

Previous 3,689 0.08%

Holding current value

$2.72 Million

Previous $2.85 Billion 7.04%

% of portfolio

1.31%

Previous 1.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 28, 2025	BUY	$725.72 - $929.72 $2,177 - $2,789	3 Added 0.08%	3,692 $3.05 Billion
Q4 2024 May 28, 2025	SELL	$727.2 - $932.06 $15,271 - $19,573	-21 Reduced 0.57%	3,689 $2.85 Billion
Q3 2024 May 28, 2025	SELL	$772.14 - $960.02 $6,177 - $7,680	-8 Reduced 0.22%	3,710 $3.29 Billion
Q1 2024 May 28, 2025	SELL	$592.2 - $792.28 $112,518 - $150,533	-190 Reduced 4.86%	3,718 $3.37 Billion
Q4 2023 May 28, 2025	BUY	$525.19 - $619.13 $43,590 - $51,387	83 Added 2.17%	3,908 $2.28 Billion
Q3 2023 May 28, 2025	BUY	$434.7 - $599.3 $8,259 - $11,386	19 Added 0.5%	3,825 $2.05 Billion
Q2 2023 May 28, 2025	SELL	$350.74 - $468.98 $272,875 - $364,866	-778 Reduced 16.97%	3,806 $1.78 Billion
Q1 2023 May 28, 2025	SELL	$310.63 - $364.82 $19,569 - $22,983	-63 Reduced 1.36%	4,584 $1.57 Billion
Q4 2022 May 28, 2025	SELL	$321.55 - $374.67 $159,488 - $185,836	-496 Reduced 9.64%	4,647 $1.7 Billion
Q3 2022 May 28, 2025	SELL	$296.48 - $337.87 $19,567 - $22,299	-66 Reduced 1.27%	5,143 $1.66 Billion
Q2 2022 May 28, 2025	SELL	$278.73 - $327.27 $28,709 - $33,708	-103 Reduced 1.94%	5,209 $1.69 Billion
Q4 2021 May 28, 2025	SELL	$224.85 - $279.04 $26,532 - $32,926	-118 Reduced 2.17%	5,312 $1.47 Billion
Q3 2021 May 28, 2025	SELL	$221.6 - $272.71 $10,415 - $12,817	-47 Reduced 0.86%	5,430 $1.25 Billion
Q2 2021 May 28, 2025	BUY	$180.55 - $233.54 $185,605 - $240,079	1,028 Added 23.11%	5,477 $1.26 Billion
Q1 2021 May 28, 2025	BUY	$164.32 - $212.72 $121,432 - $157,200	739 Added 19.92%	4,449 $831 Million
Q4 2020 May 28, 2025	BUY	$130.46 - $172.63 $521 - $690	4 Added 0.11%	3,710 $626 Million
Q3 2020 May 28, 2025	BUY	$146.22 - $169.13 $584 - $676	4 Added 0.11%	3,706 $549 Million
Q2 2020 May 28, 2025	BUY	$136.42 - $164.18 $109,545 - $131,836	803 Added 27.7%	3,702 $608 Million
Q1 2020 May 28, 2025	BUY	$119.05 - $147.35 $476 - $589	4 Added 0.14%	2,899 $402 Million
Q4 2019 May 28, 2025	BUY	$106.92 - $132.43 $427 - $529	4 Added 0.14%	2,895 $380 Million
Q3 2019 May 28, 2025	BUY	$106.79 - $116.16 $427 - $464	4 Added 0.14%	2,891 $323 Million
Q2 2019 May 28, 2025	BUY	$110.79 - $129.32 $443 - $517	4 Added 0.14%	2,887 $320 Million
Q1 2019 May 28, 2025	BUY	$111.31 - $131.02 $320,906 - $377,730	2,883 New	2,883 $374 Million

Others Institutions Holding LLY

# of Institutions

4,388

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $701B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Management Associates, Inc. with notifications on news.

Account

Wealth Management Associates, Inc. Eli Lilly & CO Transaction History